Leap Therapeutics (LPTX)
(Delayed Data from NSDQ)
$2.77 USD
-0.07 (-2.46%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.76 -0.01 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.46 | 0.00% |
Earnings Summary
For their last quarter, Leap Therapeutics (LPTX) reported earnings of -$0.52 per share, missing the Zacks Consensus Estimate of -$0.42 per share. This reflects a negative earnings surprise of 23.81%. Look out for LPTX's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year increase of 9.8%.
Earnings History
Price & Consensus
Zacks News for LPTX
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
LPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services